ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
3,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
4,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
6,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
8,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
9,1,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
9,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
9,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
10,1,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
10,2,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
10,3,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
10,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
11,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
12,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
12,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
13,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
13,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
13,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
14,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
15,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Deposit eye,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
17,1,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
17,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
18,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
18,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
19,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
21,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
22,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
23,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
24,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
25,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
26,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
27,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
27,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
28,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
29,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
29,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
30,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
31,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
31,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
33,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
34,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
35,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
37,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
38,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
39,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
39,2,Peripheral nerve injury,Peripheral nerve injuries,Injuries NEC,Inj&P,N
40,1,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
40,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
40,3,Pupillary light reflex tests abnormal,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
41,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
41,2,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
41,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
42,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
43,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
44,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
45,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
45,3,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
46,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
47,1,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
47,2,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
47,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
48,1,Disorder of orbit,Ocular disorders NEC,Eye disorders NEC,Eye,N
49,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
49,2,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
49,3,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
49,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
49,5,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
49,6,Parophthalmia,"Orbital infections, inflammations and irritations","Ocular infections, irritations and inflammations",Eye,N
49,7,Parophthalmia,"Orbital infections, inflammations and irritations","Ocular infections, irritations and inflammations",Eye,N
49,8,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
50,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
50,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
51,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
52,1,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
52,2,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
53,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
54,1,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
55,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
56,1,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
57,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
57,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
57,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
58,1,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
58,2,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
58,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
58,4,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
58,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
58,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
58,7,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
58,8,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
58,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
58,10,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
59,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
59,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
60,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
60,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
60,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
60,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
61,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
61,2,Trigeminal palsy,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
62,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
62,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
62,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
63,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
64,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
64,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
65,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
66,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
66,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
68,1,Circumoral oedema,Angioedemas,Angioedema and urticaria,Skin,N
68,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
68,3,Oral mucosal erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
68,4,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
69,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
69,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,4,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,5,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
69,6,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,7,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
69,9,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,10,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
69,11,Nail infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
69,12,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
69,13,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
69,14,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
69,15,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
70,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
70,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
70,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
70,4,Staphylococcus test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
70,5,Wound infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
71,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
71,2,Eye contusion,Eye injuries NEC,Injuries NEC,Inj&P,N
71,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
71,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
71,5,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
71,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
71,7,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
71,8,Headache,Headaches NEC,Headaches,Nerv,N
71,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
71,10,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
71,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
71,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
71,13,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
71,14,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
71,15,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
72,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
72,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
72,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
73,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
73,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
74,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
74,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
74,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
74,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
75,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
75,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
76,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
76,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
77,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
78,1,Anaesthetic complication neurological,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
78,2,Brain stem syndrome,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
78,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
78,4,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
79,1,Dermatochalasis,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
79,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
79,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
79,4,Facial asymmetry,"Musculoskeletal and connective tissue deformities of skull, face and buccal cavity",Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
79,5,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
79,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
79,7,Skin indentation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
79,8,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
79,9,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
80,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
80,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
80,3,Product solubility abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
80,4,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
80,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
81,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
81,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
81,3,Headache,Headaches NEC,Headaches,Nerv,N
81,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
81,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
82,1,Device dislocation,Device issues NEC,Device issues,Prod,N
82,2,Foreign body in eye,Eye injuries NEC,Injuries NEC,Inj&P,N
82,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
82,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
83,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
83,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
83,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
83,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
84,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
85,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
86,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
86,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
86,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
86,4,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
86,5,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
86,6,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
86,7,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
86,8,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
86,9,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
86,10,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
86,11,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
86,12,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
86,13,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
86,14,Blood phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
86,15,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
86,16,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
86,17,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
86,18,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
86,19,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
86,20,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
86,21,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
86,22,Death,Death and sudden death,Fatal outcomes,Genrl,Y
86,23,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
86,24,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
86,25,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
86,26,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
86,27,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
86,28,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
86,29,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
86,30,Headache,Headaches NEC,Headaches,Nerv,N
86,31,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
86,32,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
86,33,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
86,34,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
86,35,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
86,36,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
86,37,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
86,38,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
86,39,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
86,40,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
86,41,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
86,42,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
86,43,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
86,44,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
86,45,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
86,46,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
86,47,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
86,48,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
86,49,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
86,50,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
86,51,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
86,52,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
86,53,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
86,54,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
86,55,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
86,56,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
86,57,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
86,58,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
86,59,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
87,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
87,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
87,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
87,4,Connective tissue disorder,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
87,5,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
87,6,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
87,7,Facial wasting,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
87,8,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
87,9,Head deformity,"Musculoskeletal and connective tissue deformities of skull, face and buccal cavity",Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
87,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
87,11,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
87,12,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
87,13,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
87,14,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
87,15,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
87,16,Soft tissue atrophy,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
87,17,Trichorrhexis,Pilar disorders NEC,Skin appendage conditions,Skin,N
88,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
88,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
88,3,Facial asymmetry,"Musculoskeletal and connective tissue deformities of skull, face and buccal cavity",Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
88,4,Facial asymmetry,"Musculoskeletal and connective tissue deformities of skull, face and buccal cavity",Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
88,5,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
88,6,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
88,7,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
88,8,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
88,9,Lid sulcus deepened,"Orbital structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
88,10,Soft tissue atrophy,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
89,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
89,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
89,3,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
89,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
89,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
90,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
90,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
91,1,Deformity,General signs and symptoms NEC,General system disorders NEC,Genrl,N
91,2,Excessive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
91,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
91,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
91,5,Skin indentation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
92,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
93,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
94,1,Deformity,General signs and symptoms NEC,General system disorders NEC,Genrl,N
94,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
94,3,Excessive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
94,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
94,5,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
94,6,Lip disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
94,7,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
94,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
94,9,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
94,10,Skin indentation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
95,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
95,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
95,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
95,4,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
95,5,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
96,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
96,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
96,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
97,1,Atrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
97,2,Histamine intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
97,3,Mast cell activation syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
97,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
97,5,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
97,6,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
98,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
98,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
98,3,Eyelid function disorder,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
98,4,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
98,5,Incorrect dosage administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
98,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
98,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
98,8,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
98,9,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
98,10,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
98,11,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
98,12,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
99,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
99,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
99,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
99,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
100,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
100,2,Facial wasting,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
100,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
100,4,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
100,5,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
100,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
100,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
100,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
101,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
101,2,Deafness,Hearing losses,Hearing disorders,Ear,N
101,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
101,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
101,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
101,6,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
101,7,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
101,8,Face injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
101,9,Facial wasting,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
101,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
101,11,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
101,12,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
101,13,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
101,14,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
101,15,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
101,16,Madarosis,Alopecias,Skin appendage conditions,Skin,N
101,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
101,18,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
101,19,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
101,20,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
101,21,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
101,22,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
101,23,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
101,24,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
101,25,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
101,26,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
101,27,Skin laxity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
101,28,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
101,29,Soft tissue atrophy,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
101,30,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
101,31,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
102,1,Abnormal sensation in eye,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
102,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
102,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
102,4,Dermatochalasis,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
102,5,Dermatochalasis,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
102,6,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
102,7,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
102,8,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
102,9,Facial wasting,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
102,10,Facial wasting,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
102,11,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
102,12,Hyaluronic acid abnormal,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
102,13,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
102,14,Lagophthalmos,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
102,15,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
102,16,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
102,17,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
102,18,Myokymia,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
102,19,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
102,20,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
102,21,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
102,22,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
102,23,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
102,24,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
102,25,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
102,26,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
102,27,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
102,28,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
102,29,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
102,30,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
102,31,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
102,32,Skin indentation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
102,33,Skin laxity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
102,34,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
102,35,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
102,36,Soft tissue atrophy,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
102,37,Soft tissue atrophy,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
102,38,Therapeutic product ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,39,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
103,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
103,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
103,3,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
103,4,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
103,5,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
103,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
103,7,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
103,8,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
103,9,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
103,10,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
103,11,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
103,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
103,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
103,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
103,15,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
103,16,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
103,17,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
103,18,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
103,19,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
103,20,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
103,21,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
103,22,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
103,23,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
103,24,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
103,25,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,26,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
103,27,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
103,28,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
104,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
105,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
105,2,Lid sulcus deepened,"Orbital structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
105,3,Skin indentation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
105,4,Skin laxity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
106,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
106,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
106,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
106,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
107,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
107,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
108,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
109,1,Abnormal sensation in eye,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
109,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
109,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
109,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
109,5,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
109,6,Facial wasting,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
109,7,Lid sulcus deepened,"Orbital structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
109,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
109,9,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
109,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
109,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
109,12,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
109,13,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
109,14,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
109,15,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
109,16,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
109,17,Skin indentation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
109,18,Skin laxity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
109,19,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
109,20,Tissue injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
110,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
110,2,Tissue injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
111,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
111,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
111,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
111,4,Permanent cosmetic dermapigmentation,Skin and subcutaneous tissue therapeutic procedures NEC,Skin and subcutaneous tissue therapeutic procedures,Surg,N
111,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
112,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
112,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
112,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
112,4,Permanent cosmetic dermapigmentation,Skin and subcutaneous tissue therapeutic procedures NEC,Skin and subcutaneous tissue therapeutic procedures,Surg,N
112,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
113,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
114,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
115,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
115,2,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
115,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
115,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
116,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
116,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
116,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
116,4,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
116,5,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
116,6,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
116,7,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
116,8,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
116,9,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
116,10,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
116,11,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
116,12,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
116,13,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
116,14,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
116,15,Blood phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
116,16,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
116,17,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
116,18,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
116,19,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
116,20,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
116,21,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
116,22,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
116,23,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
116,24,Death,Death and sudden death,Fatal outcomes,Genrl,Y
116,25,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
116,26,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
116,27,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
116,28,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
116,29,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
116,30,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
116,31,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
116,32,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
116,33,Headache,Headaches NEC,Headaches,Nerv,N
116,34,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
116,35,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
116,36,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
116,37,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
116,38,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
116,39,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
116,40,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
116,41,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
116,42,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
116,43,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
116,44,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
116,45,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
116,46,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
116,47,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,48,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,49,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
116,50,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
116,51,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
116,52,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
116,53,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
116,54,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
116,55,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
116,56,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
116,57,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
116,58,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
116,59,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
116,60,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
116,61,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
116,62,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,63,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,64,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,65,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,66,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
117,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
118,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
119,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
119,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
120,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
120,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
120,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
120,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
120,5,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
121,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
121,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
121,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
121,4,Heat oedema,Heat injuries (excl thermal burns),Injuries by physical agents,Inj&P,N
121,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
121,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
121,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
122,1,Collagen disorder,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
122,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
122,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
122,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
122,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
122,6,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
122,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
123,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
124,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
125,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
125,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
126,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
126,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
126,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
126,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
126,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
126,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
126,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
126,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
126,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
127,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
127,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
128,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
129,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
129,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
129,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
129,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
129,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
129,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
129,7,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
